Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects (CROSBI ID 321124)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Riad, Abanoub ; Schünemann, Holger ; Attia, Sameh ; Poklepović Peričić, Tina ; Žuljević, Marija Franka ; Jürisson, Mikk ; Kalda, Ruth ; Lang, Katrin ; Morankar, Sudhakar ; Yesuf, Elias Ali et al. COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects // International journal of environmental research and public health, 18 (2021), 15; 7859, 10. doi: 10.3390/ijerph18157859

Podaci o odgovornosti

Riad, Abanoub ; Schünemann, Holger ; Attia, Sameh ; Poklepović Peričić, Tina ; Žuljević, Marija Franka ; Jürisson, Mikk ; Kalda, Ruth ; Lang, Katrin ; Morankar, Sudhakar ; Yesuf, Elias Ali ; Mekhemar, Mohamed ; Danso- Appiah, Anthony ; Sofi-Mahmudi, Ahmad ; Pérez-Gaxiola, Giordano ; Dziedzic, Arkadiusz ; Apóstolo, João ; Cardoso, Daniela ; Marc, Janja ; Moreno-Casbas, Mayte ; Wiysonge, Charles Shey ; Qaseem, Amir ; Gryschek, Anna ; Tadić, Ivana ; Hussain, Salman ; Khan, Mohammed Ahmed ; Klugarova, Jitka ; Pokorna, Andrea ; Koščík, Michal ; Klugar, Miloslav

engleski

COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects

Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi- country, three-phase study including a cross- sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population ; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.

cohort studies ; cross-sectional studies ; COVID-19 ; drug-related side effects and adverse reactions ; health personnel ; mass vaccination ; prevalence

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

18 (15)

2021.

7859

10

objavljeno

1660-4601

10.3390/ijerph18157859

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost